57508-53-9 Usage
Properties
1. Chemical Formula: C9H11ClN2O3
2. Function: Photoactive compound
3. Light Sensitivity: Highly light-sensitive
4. Photochemical Reaction: Undergoes a photochemical reaction upon exposure to light
5. Application: Used in photoresist materials for semiconductor manufacturing
6. Photolithography: Used in photolithography processes to create microstructures on substrates
7. Potential Use: Cationic photoinitiator in polymerization
8. Polymerization Type: Used in the polymerization of acrylates and methacrylates
9. Importance: Significant in materials science and semiconductor industry
10. Microfabrication: Essential for microfabrication processes
Function
Photoactive compound
Application
Photoresist materials for semiconductor manufacturing
Light Sensitivity
Highly light-sensitive
Photochemical Reaction
Occurs upon exposure to light
Photolithography
Utilized to create microstructures on substrates
Potential Use
Cationic photoinitiator
Polymerization
Used in polymerization of acrylates and methacrylates
Importance
Significant in materials science and semiconductor industry
Microfabrication
Crucial for microfabrication processes
This breakdown encapsulates the main properties and specific content regarding alpha-ethoxy-m-nitrobenzylideneammonium chloride based on the provided material.
Check Digit Verification of cas no
The CAS Registry Mumber 57508-53-9 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,7,5,0 and 8 respectively; the second part has 2 digits, 5 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 57508-53:
(7*5)+(6*7)+(5*5)+(4*0)+(3*8)+(2*5)+(1*3)=139
139 % 10 = 9
So 57508-53-9 is a valid CAS Registry Number.
57508-53-9Relevant articles and documents
Tetrazine-mediated bioorthogonal prodrug-prodrug activation
Neumann, Kevin,Gambardella, Alessia,Lilienkampf, Annamaria,Bradley, Mark
, p. 7198 - 7203 (2018)
The selective and biocompatible activation of prodrugs within complex biological systems remains a key challenge in medical chemistry and chemical biology. Herein we report, for the first time, a dual prodrug activation strategy that fully satisfies the principle of bioorthogonality by the symbiotic formation of two active drugs. This dual and traceless prodrug activation strategy takes advantage of the INVDA chemistry of tetrazines (here a prodrug), generating a pyridazine-based miR21 inhibitor and the anti-cancer drug camptothecin and offers a new concept in prodrug activation.
DNA Binding Compounds. VI. Synthesis and Characterization of 2,5'-Disubstituted Bibenzimidazoles Related to the DNA Minor Groove Hoechst 33258
Kelly, David P.,Bateman, Stuart A.,Hook, Robert J.,Martin, Roger F.,Reum, Monica E.,et al.
, p. 1751 - 1770 (2007/10/02)
A series of compounds have been synthesized in which the basic 2-phenylbibenzimidazole structure of Hoechst 33258 has been modified to include various combinations of bromo, iodo, methoxy, amino, alkylamino and nitro groups in the terminal phenyl ring.Both sequential and convergent synthetic routs have been followed using coupling reactions of both imino ethers and aldehydes to 1,2-diamines.All these compounds were characterized by a combination of f.a.b. mass spectrometry and 1H and 13C n.m.r. spectroscopy including inverse detection of long-range heteronuclear CH correlations (HMBC).
